Cargando…
Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling
BACKGROUND: Analytical validity is a prerequisite to use a next generation sequencing (NGS)-based application as an in vitro diagnostic test or a companion diagnostic in clinical practice. Currently, in the United States and the European Union, the intended use of such NGS-based tests does not refer...
Autores principales: | Huebner, Tatjana, Steffens, Michael, Scholl, Catharina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635985/ https://www.ncbi.nlm.nih.gov/pubmed/37787843 http://dx.doi.org/10.1007/s11033-023-08748-z |
Ejemplares similares
-
Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe
por: Huebner, Tatjana, et al.
Publicado: (2021) -
Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe
por: Huebner, Tatjana, et al.
Publicado: (2021) -
Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data
por: Zhou, Yitian, et al.
Publicado: (2018) -
Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling
por: Plagnol, Vincent, et al.
Publicado: (2018) -
Current Status of Next-Generation Sequencing in Bone Genetic Diseases
por: Aida, Natsuko, et al.
Publicado: (2023)